COH
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

Cochlear Limited is a medical technology company that designs and manufactures implantable hearing devices. The company operates through three primary business segments: Cochlear Implants, Services, and Acoustics. Its core product line includes the Nucleus Nexa System, the Nucleus Kanso 3 Sound Processor, and the Osia Implant for acoustic neuromas. The Services segment provides sound processor upgrades and clinical support, while the Acoustics segment offers the Osia Implant and the Baha 7 Sound Processor for bone conduction hearing. Cochlear serves patients with hearing loss in developed and emerging markets, with a specific strategic focus on the adults and seniors demographic. The company utilizes a Connected Care ecosystem, including Remote Check and Remote Assist tools, to support healthcare professionals in patient management. Cochlear holds an investment in Saluda, a subsidiary involved in hearing technology. The company's products are distributed globally, with significant operations in Europe, Asia Pacific, and the United States.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Health Care Equipment & Services Homepage cochlear.com
Sector Healthcare IR page —
Tags
cochlear implants, acoustic implants, sound processors, bone conduction, hearing loss, remote care, medical technology, Nucleus Nexa, Nucleus Kanso 3, Osia Implant, Baha 7, Osia 2(I), Nucleus 8, Nucleus 7, Saluda, Remote Check, Remote Assist, Connected Care
Press page —

Metrics

Valuation  
Market cap A$ 10.005B
Market cap (USD) $ 6.789B
P/E 60.16
PEG —
P/BV 6.20
P/S 6.07
P/OCF 27.19
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 8.7%
ROI 10.3%
ROIC 8.7%
Profit margin —
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -12.5%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue — — 1.648B 1.498B 1.321B 1.427B 1.364B 1.254B 1.131B 925.63M 804.936M 752.721M 778.996M 809.646M 734.803M
Net profit 147.3M 388.9M 289.1M 323.8M -238.3M 276.7M 245.8M 223.6M 188.921M 145.84M 93.709M 132.563M 56.803M 180.114M 155.152M

Figure FY 2026 FY 2025 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price 121.75 300.42 198.7 — — — — — — — — — — — —
Price performance 12m -0.59 -0.1 — — — — — — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Notification regarding unquoted securities - COH Bull 0 Bear 0 Routine
Appendix 3Y - Diggory Howitt Bull 0 Bear 0 Routine
Appendix 3Y - Michael del Prado Bull 0 Bear 0 Routine

Prompts

Cochlear Limited (ticker COH), listed in Australia.

ETFs Holding Cochlear Limited

ETF Weight in ETF Shares Market value As of
AVSD 0.04% 1,651 $ 166.538K Nov 16, 2026
JSTC 0.03% 865 $ 88.059K Nov 17, 2026
NTSI 0.02% 995 $ 83.927K Jun 30, 2026
AVDE 0.01% 16,188 $ 1.633M Nov 16, 2026
DFAX 0.01% 9,295 $ 968.347K Nov 12, 2026
DFAI 0.00% 5,566 $ 579.862K Nov 12, 2026
DFIC 0.00% 4,613 $ 480.579K Nov 12, 2026